Crescent Biopharma, Inc. Common Stock Share Price
NASDAQ: CBIOHealthcare
Live Crescent Biopharma, Inc. Common Stock Share Price Chart
O H L
Crescent Biopharma, Inc. Common Stock Performance Overview
Days Range
▼
$16.36Low
$17.36High
Markets Today
| Previous Close | $16.77 |
|---|---|
| Open | $16.52 |
| Volume | 157,608 |
| Day's Range | $16.36 - $17.36 |
| 52W Range | NA |
| Market Cap | $638.18 M |
Historical Performance
| 1M Returns | +0.48 |
|---|---|
| 3M Returns | -5.20 |
| 6M Returns | +62.03 |
| 1Y Returns | +29.60 |
| 5Y Returns | -78.42 |
| 10Y Returns | -15.30 |
Crescent Biopharma, Inc. Common Stock Fundamentals
| Market Cap | $638.18 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $10.84 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-152.55 M |
| Profit Margin | -1230.60 |
| Market Cap | $638.18 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $10.84 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-152.55 M |
| Profit Margin | -1230.60 |
Crescent Biopharma, Inc. Common Stock Profit & Loss
Quarterly
| Sep 2023 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $32.04 M | $0 | $0 | $10.84 M | $1.04 M | $0 |
| Gross Profit + | $30.86 M | $0 | $0 | $10.84 M | $1.04 M | $0 |
| Operating Income | $12.76 M | -$21.03 M | -$25.89 M | -$91.49 M | -$24.73 M | -$26.36 M |
| EBITDA | $12.96 M | -$21.03 M | -$25.86 M | -$91.44 M | -$24.66 M | -$26.30 M |
| Interest Expense | $0 | -$1.07 M | $0 | $0 | $0 | $0 |
| Depreciation | $192.00 K | $2.00 K | $28.00 K | $54.00 K | $64.00 K | $66.00 K |
| Income Before Tax | $11.19 M | -$21.79 M | -$24.61 M | -$90.40 M | -$23.28 M | -$24.84 M |
| Income Tax Expense | $3.68 M | $0 | $0 | $2.00 M | $0 | $0 |
| Net Income + | $7.51 M | -$21.79 M | -$24.61 M | -$92.40 M | -$23.28 M | -$24.84 M |
| Net Profit Margin | 23.44% | - | - | -852.06% | -2240.9% | - |
Crescent Biopharma, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Sep 2023 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $37.00 K | $14.00 K | $14.00 K | $28.00 K | $28.00 K | $28.00 K |
| Reserve & Surplus | -$414.72 M | -$54.80 M | -$79.41 M | -$171.81 M | -$195.09 M | -$219.93 M |
| Non-Current Liabilities | $4.66 M | $1.43 M | $1.32 M | $1.21 M | $1.09 M | $966.00 K |
| Current Liabilities | $1.78 M | $16.75 M | $20.30 M | $36.07 M | $14.19 M | $18.54 M |
| Total Liabilities | $6.45 M | $18.18 M | $21.63 M | $37.28 M | $15.28 M | $19.50 M |
| Fixed Assets | $0 | $193.00 K | $782.00 K | $846.00 K | $929.00 K | $876.00 K |
| Current Assets | $5.13 M | $154.23 M | $134.56 M | $236.66 M | $195.56 M | $179.01 M |
| Total Assets | $9.96 M | $157.43 M | $138.27 M | $240.29 M | $199.13 M | $182.76 M |
Crescent Biopharma, Inc. Common Stock Cash Flow
Quarterly
| Sep 2023 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $7.51 M | -$21.79 M | -$24.61 M | -$92.40 M | -$23.28 M | -$24.84 M |
| Operating Cash Flow | $7.58 M | -$16.40 M | -$17.54 M | -$26.74 M | -$8.94 M | -$19.46 M |
| Investing Cash Flow | -$5.40 M | -$140.00 K | -$586.00 K | -$72.19 M | -$8.15 M | $1.76 M |
| Financing Cash Flow | $0 | $146.86 M | -$1.25 M | $178.86 M | -$6.95 M | $136.00 K |
| Change in Cash | $2.35 M | $130.32 M | -$19.38 M | $79.93 M | -$24.03 M | -$17.57 M |
Crescent Biopharma, Inc. Common Stock Return Calculator
The Crescent Biopharma, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,215
Invested Amount$10,000
Est. Returns$-7,785
About Crescent Biopharma, Inc. Common Stock
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. The company focuses on advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.
Popular Stocks
FAQs
What is the share price of Crescent Biopharma, Inc. Common Stock today?
Crescent Biopharma, Inc. Common Stock (CBIO) share price as of September 18, 2026 is $17.21. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Crescent Biopharma, Inc. Common Stock?
Yes, Indian Investors can invest in the Crescent Biopharma, Inc. Common Stock (CBIO) Share by opening an international trading account with Angel One.
How can I purchase Crescent Biopharma, Inc. Common Stock shares in India?
Purchasing Crescent Biopharma, Inc. Common Stock (CBIO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Crescent Biopharma, Inc. Common Stock (CBIO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Crescent Biopharma, Inc. Common Stock?
Yes, you can purchase fractional shares of Crescent Biopharma, Inc. Common Stock (CBIO) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Crescent Biopharma, Inc. Common Stock?
The market capitalization of Crescent Biopharma, Inc. Common Stock on September 18, 2026, is $638.18 M.
In which sector Crescent Biopharma, Inc. Common Stock belongs?
Crescent Biopharma, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Crescent Biopharma, Inc. Common Stock stocks?
In order to invest in Crescent Biopharma, Inc. Common Stock (CBIO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
